ANNX as of Nov 2 · 16:32 ET
ANNXNasdaqPharmaceutical Preparations

Annexon, Inc. · Brief

Next report

7 days

Nov 9 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

8 reportsHistory
0 of 7≥ implied
avg implied
±22.3%
avg realized
±3.2%
Nov 14 '24±12.1%▼−3.32%×0.27
Mar 3 '25—▲+3.35%—
May 12 '25±34.0%▼−1.13%×0.03
Aug 14 '25±15.5%▲+2.52%×0.16
Q3 FY25±15.8%▼−0.34%×0.02
Q1 FY26±13.7%▲+11.69%×0.85
May 7 '26±53.1%▲+3.08%×0.06
Q2 FY26±11.9%▼−0.19%×0.02
quarterimplied−55%0+55%realized×
Q2 FY26±11.9%▼−0.19%×0.02
May '26±53.1%▲+3.08%×0.06
Q1 FY26±13.7%▲+11.69%×0.85
Q3 FY25±15.8%▼−0.34%×0.02
Aug '25±15.5%▲+2.52%×0.16
May '25±34.0%▼−1.13%×0.03
2 older reports
Mar '25—▲+3.35%—
Nov '24±12.1%▼−3.32%×0.27
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

217managers reporting a position in the latest quarterly filings13F · Jun 30 '26
4tracked funds holding ANNXN-PORT · Aug 31 '26

Bear2 of 3

7 of 7recent reports where the move came in under the options-implied rangeEarnings history
8 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ANNX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 26impliedImplied move: ±56.5% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.